Tag
By Rachel Ellis
“When more Black men with RA can connect, advocate, and participate in clinical trials, we don’t just create community, we move the needle on the development of drugs that will help people of color have better control over their disease,” says rheumatoid arthritis patient Aberdeen “Deen” Allen.
By CreakyStaff
Learn more about different factors that cause pain in rheumatoid arthritis and how to work with your doctor to treat RA pain.
A head-to-head study looked at how RA patients who didn’t do well on their first biologic fared when they switched to either upadacitinib (Rinvoq) or abatacept (Orencia).
A study of more than 140,000 Medicare patients with rheumatoid arthritis found that those on any biologic drug were 17 percent less likely than those using only a traditional DMARD to have developed dementia.
By CreakyStaff
The American College of Rheumatology’s 2020 medical conference had a number of important updates that people living with rheumatoid arthritis (or their caregivers) should know about, from new RA treatment guidelines to new insights about managing comorbidities.
By Kelsey Kloss
New research shows that use of hydroxychloroquine did not predict prolonged QTc, a key measure of heart rate.
By Kelsey Kloss
New research sheds more light on the racial health disparities that exist in arthritis treatments.
Rheumatoid arthritis patient Eileen Davidson has had her share of doctor visits virtually and in person. Here’s her take on the good and bad of telehealth — and why it’s transformed her care.
A new study found that people with rheumatoid arthritis patients had a higher risk of deep vein thrombosis and pulmonary embolism compared to the general population, but people in high disease activity were much more at risk than those in remission.
Start by avoiding ableism and toxic positivity.
By 
By 
